Inventor
HOU JINZHAO
US31 patents
⚠️ This page may combine multiple inventors who share the name “HOU JINZHAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VOYAGER THERAPEUTICS INC
24 patentsUS10597660B2Mar 24, 2020
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC11 citations93
US10584337B2Mar 10, 2020
Modulatory polynucleotides
VOYAGER THERAPEUTICS INC15 citations91
US11603542B2Mar 14, 2023
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC7 citations85
US10570395B2Feb 25, 2020
Modulatory polynucleotides
VOYAGER THERAPEUTICS INC13 citations84
US11859200B2Jan 2, 2024
AAV capsids with increased tropism to brain tissue
VOYAGER THERAPEUTICS INC5 citations83
US11198873B2Dec 14, 2021
Modulatory polynucleotides
VOYAGER THERAPEUTICS INC7 citations83
US11193129B2Dec 7, 2021
Modulatory polynucleotides
VOYAGER THERAPEUTICS INC8 citations83
US10920227B2Feb 16, 2021
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC8 citations83
US10577627B2Mar 3, 2020
Chimeric capsids
VOYAGER THERAPEUTICS INC6 citations83
US11434502B2Sep 6, 2022
Treatment of amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC5 citations82
US11752181B2Sep 12, 2023
Compositions and methods of treating Huntington's disease
VOYAGER THERAPEUTICS INC4 citations73
US11542506B2Jan 3, 2023
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC3 citations72
US11512327B2Nov 29, 2022
Compositions and methods for delivery of AAV
VOYAGER THERAPEUTICS INC3 citations71
US12467046B2Nov 11, 2025
Redirection of tropism of AAV capsids
VOYAGER THERAPEUTICS INC0 citations62
US11951121B2Apr 9, 2024
Compositions and methods for treating Huntington's disease
VOYAGER THERAPEUTICS INC0 citations62
US12180500B2Dec 31, 2024
Chimeric capsids
VOYAGER THERAPEUTICS INC0 citations61
US12123002B2Oct 22, 2024
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC0 citations61
US12071625B2Aug 27, 2024
Modulatory polynucleotides
VOYAGER THERAPEUTICS INC0 citations61
US12577588B2Mar 17, 2026
AAV capsids with increased tropism to brain tissue
VOYAGER THERAPEUTICS INC0 citations60
US12305189B2May 20, 2025
Compositions and methods for delivery of AAV
VOYAGER THERAPEUTICS INC0 citations60
US12281321B2Apr 22, 2025
Frataxin expression constructs having engineered promoters and methods of use thereof
VOYAGER THERAPEUTICS INC0 citations59
US12084659B2Sep 10, 2024
Modulatory polynucleotides
VOYAGER THERAPEUTICS INC0 citations59
US12146150B2Nov 19, 2024
Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery
VOYAGER THERAPEUTICS INC0 citations57
US12116589B2Oct 15, 2024
Treatment of amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC0 citations57